RayKnowChina Research Map
Shortlist

Not yet recruitingCoronary heart diseaseN/A

Registered title, quoted from ClinicalTrials.gov

Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System

An open trial on coronary heart disease, registered on ClinicalTrials.gov. The lead sponsor is not a hospital on this site; 67 hospitals on this site are listed as study sites.

Status, phase and start date as registered on ClinicalTrials.gov on 18 Nov 2026; the registry may have changed since. Whether someone can take part is decided by the study team. Not medical advice.

The study team’s contact details are on the registry record. This site does not pass on enquiries.

Hospitals in mainland China listed for this trial 67

Hospitals on this site that the registry record names as lead sponsor or study site, where the site is open. Lead sponsor first, then study sites A–Z.

  1. Study siteAffiliated Hospital of Guangdong Medical University广东医科大学附属医院ZhanjiangHospital page
  2. Study siteAffiliated Hospital of Qingdao University青岛大学附属医院QingdaoHospital page
  3. Study siteAffiliated Hospital of Xuzhou Medical University徐州医科大学附属医院XuzhouHospital page
  4. Study siteAffiliated Zhongshan Hospital of Dalian University大连大学附属中山医院ZhongshanHospital page
  5. Study siteBeijing Anzhen Hospital首都医科大学附属北京安贞医院BeijingHospital page
  6. Study siteBeijing Chao-Yang Hospital首都医科大学附属北京朝阳医院BeijingHospital page
  7. Study siteBeijing Friendship Hospital首都医科大学附属北京友谊医院BeijingHospital page
  8. Study siteBeijing Luhe Hospital首都医科大学附属北京潞河医院BeijingHospital page
  9. Study siteCangzhou Central Hospital沧州市中心医院TianjinHospital page
  10. Study siteChanghai Hospital海军军医大学第一附属医院(长海医院)ShanghaiHospital page
  11. Study siteChangzheng Hospital海军军医大学第二附属医院(长征医院)ShanghaiHospital page
  12. Study siteChina-Japan Union Hospital, Jilin University吉林大学白求恩第三医院(中日联谊医院)ChangchunHospital page
  13. Study siteFifth Affiliated Hospital of Sun Yat-sen University中山大学附属第五医院ZhuhaiHospital page
  14. Study siteFirst Affiliated Hospital of Anhui Medical University安徽医科大学第一附属医院HefeiHospital page
  15. Study siteFirst Affiliated Hospital of Bengbu Medical University蚌埠医学院第一附属医院BengbuHospital page
  16. Study siteFirst Affiliated Hospital of Chongqing Medical University重庆医科大学附属第一医院ChongqingHospital page
  17. Study siteFirst Affiliated Hospital of Guangxi Medical University广西医科大学第一附属医院NanningHospital page
  18. Study siteFirst Affiliated Hospital of Henan University of Chinese Medicine河南中医药大学第一附属医院ZhengzhouHospital page
  19. Study siteFirst Affiliated Hospital of Henan University of Science and Technology河南科技大学第一附属医院LuoyangHospital page
  20. Study siteFirst Affiliated Hospital of Nanchang University南昌大学第一附属医院NanchangHospital page
  21. Study siteFirst Affiliated Hospital of Xi'an Jiaotong University西安交通大学第一附属医院Xi'anHospital page
  22. Study siteFirst Affiliated Hospital of Zhengzhou University郑州大学第一附属医院ZhengzhouHospital page
  23. Study siteFirst Hospital of Jilin University吉林大学第一医院ChangchunHospital page
  24. Study siteFirst Hospital of Lanzhou University兰州大学第一医院LanzhouHospital page
  25. Study siteFuwai Central China Cardiovascular Hospital阜外华中心血管病医院ZhengzhouHospital page
  26. Study siteFuwai Yunnan Cardiovascular Hospital云南省阜外心血管病医院KunmingHospital page
  27. Study siteGeneral Hospital of Ningxia Medical University宁夏医科大学总医院YinchuanHospital page
  28. Study siteGuangdong Provincial Hospital of Chinese Medicine广东省中医院GuangzhouHospital page
  29. Study siteGuizhou Provincial People's Hospital贵州省人民医院GuiyangHospital page
  30. Study siteHainan General Hospital / Hainan Medical University hospitals海南医学院附属医院/海南省人民医院HaikouHospital page
  31. Study siteHebei General Hospital河北省人民医院ShijiazhuangHospital page
  32. Study siteHenan Provincial Chest Hospital河南省胸科医院ZhengzhouHospital page
  33. Study siteHenan Provincial People's Hospital河南省人民医院ZhengzhouHospital page
  34. Study siteHuai'an First People's Hospital淮安市第一人民医院Huai'anHospital page
  35. Study siteJiangsu Province Hospital江苏省人民医院(南医大一附院)NanjingHospital page
  36. Study siteJiangxi Provincial People's Hospital江西省人民医院NanchangHospital page
  37. Study siteLanzhou University Second Hospital兰州大学第二医院LanzhouHospital page
  38. Study sitePeking Union Medical College Hospital北京协和医院BeijingHospital page
  39. Study sitePeking University Third Hospital北京大学第三医院BeijingHospital page
  40. Study siteQilu Hospital of Shandong University山东大学齐鲁医院JinanHospital page
  41. Study siteRenmin Hospital of Wuhan University武汉大学人民医院WuhanHospital page
  42. Study siteRuijin Hospital上海交通大学医学院附属瑞金医院ShanghaiHospital page
  43. Study siteSecond Affiliated Hospital of Chongqing Medical University重庆医科大学附属第二医院ChongqingHospital page
  44. Study siteSecond Affiliated Hospital of Harbin Medical University哈尔滨医科大学附属第二医院HarbinHospital page
  45. Study siteSecond Affiliated Hospital of Nanchang University南昌大学第二附属医院NanchangHospital page
  46. Study siteSecond Affiliated Hospital of Xi'an Jiaotong University西安交通大学第二附属医院Xi'anHospital page
  47. Study siteSecond Affiliated Hospital of Zhengzhou University郑州大学第二附属医院ZhengzhouHospital page
  48. Study siteSecond Affiliated Hospital, Zhejiang University浙江大学医学院附属第二医院HangzhouHospital page
  49. Study siteSecond Hospital of Jilin University吉林大学第二医院ChangchunHospital page
  50. Study siteSecond Hospital of Shanxi Medical University山西医科大学第二医院TaiyuanHospital page
  51. Study siteShanghai Chest Hospital上海市胸科医院ShanghaiHospital page
  52. Study siteShanghai East Hospital, Tongji University同济大学附属东方医院ShanghaiHospital page
  53. Study siteShanghai General Hospital上海市第一人民医院ShanghaiHospital page
  54. Study siteShanghai Sixth People's Hospital上海市第六人民医院ShanghaiHospital page
  55. Study siteShantou University Medical College hospitals汕头大学医学院附属医院ShantouHospital page
  56. Study siteShanxi Cardiovascular Hospital山西省心血管医院TaiyuanHospital page
  57. Study siteSir Run Run Shaw Hospital浙江大学医学院附属邵逸夫医院HangzhouHospital page
  58. Study siteTangdu Hospital空军军医大学唐都医院Xi'anHospital page
  59. Study siteTianjin Chest Hospital天津市胸科医院TianjinHospital page
  60. Study siteUnion Hospital华中科技大学同济医学院附属协和医院WuhanHospital page
  61. Study siteXiangya Hospital中南大学湘雅医院ChangshaHospital page
  62. Study siteXinhua Hospital上海交通大学医学院附属新华医院ShanghaiHospital page
  63. Study siteXuanwu Hospital首都医科大学宣武医院BeijingHospital page
  64. Study siteYantai Yuhuangding Hospital烟台毓璜顶医院YantaiHospital page
  65. Study siteZhongda Hospital, Southeast University东南大学附属中大医院NanjingHospital page
  66. Study siteZhongnan Hospital of Wuhan University武汉大学中南医院WuhanHospital page
  67. Study siteZibo Central Hospital淄博市中心医院ZiboHospital page

The record may name more sites, including outside mainland China, and sites can open or close during a trial. Full list of sites on ClinicalTrials.gov

Source: ClinicalTrials.gov record NCT04995159, read on 18 Nov 2026; hospital names matched to this site’s hospital list. How names are matched

Checklist for this trial 2

Only the points this trial’s record answers definitely: the registered age and sex, and criteria lines that state a number, score, stage or named test, quoted word for word. Tick a point once it has been compared with the medical records.

Show the checklist (2 points)Hide the checklist
  1. 18 years to Not stated; sex: all

    Registered eligibility fields

  2. Age 18 or above, male or non-pregnant female.

    Inclusion criterion 1

    Patients who are pregnant, breastfeeding, or planning to become pregnant during the study period.

    Exclusion criterion 9

Ticks stay on this page; they are not saved or sent. Meeting every point is not enough: the study team decides after its own screening. Lines that need the team’s judgement, such as “sufficient organ function”, are not in this list; they are in the full criteria below. Not stated definitely in this record: diagnosis and how it was confirmed; stage or severity, as the trial defines it; earlier treatment; day-to-day activity level; blood tests: counts, liver and kidney function; scans and measurable lesions; other conditions the trial excludes.

Questions to ask the study team

Picked from the record by fixed keyword rules (not by AI, not checked by hand) and quoted from ClinicalTrials.gov, NCT04995159, read on 10 Nov 2026.

Registered criteria

Quoted as registered on ClinicalTrials.gov, in English, read on 10 Nov 2026. This site has not checked, shortened or translated them. Meeting the written criteria is not enough: the study team decides after its own screening.

Inclusion Criteria:

  • Age 18 or above, male or non-pregnant female.
  • Evidence of myocardial ischemia (e.g., stable angina, unstable angina, medium-low risk NSTEMI, STEMI with onset more than 1 week, old myocardial infarction or asymptomatic myocardial ischemia), and suitable for PCI surgery.
  • The target lesion is in-situ coronary artery lesion, the total length of single lesion is no more than 40mm (the total length of stent is no more than 48mm), and the diameter of the target lesion is between 2.75mm and 3.75mm (visual measurement).
  • The diameter stenosis of target lesion is ≥70% in visual (or ≥50% with clinical evidence of myocardial ischemia in that range), and the TIMI blood flow is greater than grade 1.
  • The stent with diameter more than 3.0mm is allowed to overlap with another stent once, the overlapping methods could be edge to edge or at most 1mm overlap. The total number of stents per patient is no more than 4, with a maximum of 2 stents per vessel (the 2.75mm diameter stent is not allowed to overlap).
  • Patient with indications for coronary artery bypass surgery.
  • Aspirin and clopidogrel could be used continuously during the study.
  • Patient who can understand the purpose of this trial, is willing to participate in the trial and to conduct clinical follow-up as required by the study protocol.

Exclusion Criteria:

  • Acute ST-segment elevation myocardial infarction within 1 week.
  • Left main coronary artery disease, branch vessel diameter≥2.0mm, three-vessel coronary artery disease and bridge vessel disease; visible thrombus in the target vessel.
  • Severe distortion, severe calcification that cannot be successfully predilated, and other lesions that are not suitable for stent delivery and deployment.
  • Intra-stent restenosis.
  • Severe heart failure (NYHA≥III or left ventricular ejection fraction<35%).
  • Severe renal insufficiency, eGFR<30ml/min/1.73m2 or serum creatinine>2.5mg/dL (221μmol/L).
  • Patients with bleeding tendency, active gastrointestinal ulcer, history of cerebral hemorrhage or subarachnoid hemorrhage, history of stroke within half a year, fundus hemorrhage affecting vision, antiplatelet agents and anticoagulant treatment contraindications who cannot receive antithrombotic therapy.
  • Patients requiring long-term oral anticoagulants during the study period.
  • Patients who are pregnant, breastfeeding, or planning to become pregnant during the study period.
  • Patients with malignancies, organ transplants, or drug addiction that can seriously affect study compliance.
  • Patients with contraindications to aspirin, clopidogrel or ticagrelor.
  • Known allergy to aspirin, clopidogrel, ticagrelor, heparin, contrast agent, polylactic acid polymer and rapamycin.
  • Thrombosis occurred during previous clopidogrel treatment.
  • Life expectancy is less than 36 months.
  • Participated in clinical trials of other drugs or medical devices before enrollment and failed to meet the time limit of the primary end point.
  • Patients who will have elective surgery within a year and need to discontinue aspirin, clopidogrel or ticagrelor.
  • Subjects are deemed unsuitable for enrollment by investigators.

Quoted from ClinicalTrials.gov, NCT04995159, participation criteria. Read on 10 Nov 2026.

Where this information comes from

The registry record

ClinicalTrials.gov (US National Library of Medicine), record NCT04995159, read on 18 Nov 2026. A trial has a page here while its overall status is recruiting, not yet recruiting or enrolling by invitation and at least one listed hospital’s site is open. Trials registered only in China’s own registry (ChiCTR) are not included.

Diseases and hospitals

The trial is listed under a disease when this site’s ClinicalTrials.gov search for that disease in China returns it. Sponsor and site names in the record are matched to this site’s hospital list (ROR identifiers, checked aliases). Definitions

What is left out

Names of investigators and contact persons in the record, and anything not in the record. The title and criteria are quoted from the record.

Suggest a correctionClinicalTrials.gov NCT04995159